Cerebral amyloid deposition predicts long‐term cognitive decline in hemorrhagic small vessel disease
Brain and Behavior · 2023
DOI: 10.1002/brb3.3189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2023. Verfasst von Ya-Chin Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Cerebral Hemorrhage, Cerebral Small Vessel Diseases, Amyloid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University Hospital Bei-Hu Branch, National Science and Technology Council.
Abstract (Originalsprache)
Background
To investigate the association between cerebral amyloid deposition and long‐term cognitive outcomes in patients with hemorrhagic small vessel disease (SVD) and survivors of intracerebral hemorrhage (ICH).
Methods
Patients experiencing an ICH without overt dementia were prospectively recruited ( n = 68) for brain MRI and Pittsburgh compound B (PiB) positron emission tomography scans at baseline. Cognitive function was assessed using the mini‐mental status examination (MMSE) and clinical dementia rating after an overall median follow‐up of 3.8 years. A positive amyloid scan was defined as a global PiB standardized uptake value ratio >1.2. Associations between follow‐up cognitive outcomes and neuroimaging markers were explored using multivariable Cox regression models.
Results
PiB(+) patients were older (72.1 ± 7.8 vs. 59.9 ± 11.7, p = .002) and more frequently had cerebral amyloid angiopathy (CAA) (63.6% vs. 15.8%, p = .002) than PiB(−) patients. PiB(+) was associated with a higher risk of dementia conversion (32.9 vs. 4.0 per 100‐person‐years, hazard ratio [HR] = 15.7 [3.0–80.7], p = .001) and MMSE score decline (58.8 vs. 9.9 per 100‐person‐years, HR = 6.2 [1.9–20.0], p = .002). In the non‐CAA subgroup ( n = 52), PiB(+) remained an independent predictor of dementia conversion, p = .04). In the Cox models, PiB(+) was an independent predictor of dementia conversion (HR = 15.8 [2.6–95.4], p = .003) and MMSE score decline (HR = 5.7 [1.6–20.3], p = .008) after adjusting for confounders.
Conclusions
Cerebral amyloid deposition potentially contributes to long‐term cognitive decline in SVD‐related ICH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
- Department of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Neurology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
ORCID-Profile: Hsin-Hsi Tsai
Förderung
- National Taiwan University Hospital Bei-Hu Branch
- National Science and Technology Council
Zitieren
APA
Tsai, Y. C., Tsai, H. H., Liu, C. J., Lin, S. S., Chen, Y. F., Jeng, J. S., Tsai, L. K., & Yen, R. F. (2023). Cerebral amyloid deposition predicts long‐term cognitive decline in hemorrhagic small vessel disease. Brain and Behavior. https://doi.org/10.1002/brb3.3189
Vancouver
Tsai YC, Tsai HH, Liu CJ, Lin SS, Chen YF, Jeng JS, et al. Cerebral amyloid deposition predicts long‐term cognitive decline in hemorrhagic small vessel disease. Brain and Behavior. 2023. doi:10.1002/brb3.3189
BibTeX
@article{Tsai2023,
author = {Tsai, Ya-Chin and Tsai, Hsin-Hsi and Liu, Chia-Ju and Lin, Sheng-Sian and Chen, Ya-Fang and Jeng, Jiann-Shing and Tsai, Li-Kai and Yen, Ruoh-Fang},
title = {Cerebral amyloid deposition predicts long‐term cognitive decline in hemorrhagic small vessel disease},
journal = {Brain and Behavior},
year = {2023},
doi = {10.1002/brb3.3189}
}
EUVIMED